Cabotegravir

VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

600 mg suspension inyectable de liberacion prolongadaSpainMarketedAuthorised 20 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VocabriaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cabotegravir

VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

600 mg suspension inyectable de liberacion prolongadaSpainMarketedAuthorised 20 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VocabriaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vocabria 400 mg suspensie voor injectie met verlengde afgifteNetherlands · Suspensie voor injectie · ViiV healthcare B.V.

Vocabria 600 mg suspensie voor injectie met verlengde afgifteNetherlands · Suspensie voor injectie · ViiV healthcare B.V.

Vocabria 30 mg, filmomhulde tabletNetherlands · Filmomhulde tablet · ViiV healthcare B.V.

Vocabria Prolonged-Release Suspension for Injection 400 MG/ 2 MLSingapore · 200 mg/ml · injection, suspension · Glaxosmithkline Pte LTD

Vocabria Prolonged-Release Suspension for Injection 600 MG/3 MLSingapore · 200mg/ml · injection, suspension · Glaxosmithkline Pte LTD

Vocabria Film-Coated Tablets 30MGSingapore · 30mg · tablet, film coated · Glaxosmithkline Pte LTD

VocabriaUnited States · 30MG BASE · tablet · Viiv Hlthcare

ApretudeItaly · Sospensione iniettabile a rilascio prolungato · Viiv Healthcare BV

ApretudeBrazil · Glaxosmithkline Brasil Ltda

ApretudeCanada · 200 MG / ML · Suspension (Extended-Release) · Viiv Healthcare Ulc

ApretudeCanada · 30 MG · Tablet · Viiv Healthcare Ulc

ApretudeEuropean Union · ViiV Healthcare B.V.

ApretudeCroatia

Apretude prolonged-release suspension for injectionTaiwan · 注射用懸液劑 · 荷商葛蘭素史克藥廠股份有限公司台灣分公司

ApretudeUnited States · 600MG/3ML · suspension, extended release · Viiv Hlthcare

Packs

Pack	Code	Status
VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial de 3 ml	730112

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cabotegravir
Strength: 600 mg
Dosage form: suspension inyectable de liberacion prolongada
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 20 Jan 2021
Registration: 1201481003
Marketing authorisation holder: Viiv Healthcare B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/20/1481

Spain

Vocabria 30 MG Comprimidos Recubiertos con PeliculaCabotegravir · 31,62 mg · comprimido recubierto con películaSpain